<DOC>
	<DOCNO>NCT00460499</DOCNO>
	<brief_summary>This study seek determine whether vary dose insulin glucose diabetic patient coronary bypass surgery improve outcome patient .</brief_summary>
	<brief_title>Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control</brief_title>
	<detailed_description>Our previous study show maintain serum glucose 120-180mg/dl perioperative period CABG surgery diabetic patient improve outcome . The purpose trial : ( 1 ) determine whether outcome improve alter content glucose insulin solution ( 2 ) determine effect solution glycemic control inflammatory response arterial venous conduit use surgery , ( 3 ) determine whether beneficial effect improve glycemic control correlate change inflammatory response .</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Diabetic CABG patient Renal hepatic failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Diabetes</keyword>
</DOC>